Publications

Force, J, Howie, LJ, Abbott, SE, Bentley, R, Marcom, PK, Kimmick, G, Westbrook, K, Sammons, SL, Parks, M, Topping, DL, Emerson, R, Broadwater, G, Hyslop, T, Blackwell, KL, and Nair, SK. "Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype." Clinical breast cancer (February 24, 2018).

PMID
29615305
Full Text

Hainsworth, JD, Meric-Bernstam, F, Swanton, C, Hurwitz, H, Spigel, DR, Sweeney, C, Burris, H, Bose, R, Yoo, B, Stein, A, Beattie, M, and Kurzrock, R. "Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIA multiple basket study." February 20, 2018.

Full Text

Clarke, JM, George, DJ, Lisi, S, and Salama, AKS. "Immune Checkpoint Blockade: The New Frontier in Cancer Treatment." Targeted oncology 13, no. 1 (February 13, 2018): 1-20.

PMID
29441437
Full Text

Zhou, X, Qiao, G, Wang, X, Song, Q, Morse, MA, Hobeika, A, Gwin, WR, Ren, J, and Lyerly, HK. "CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine." Cancer chemotherapy and pharmacology 81, no. 2 (February 2018): 365-372.

PMID
29242966
Full Text

Feldman, DR, Ardeshir-Rouhani-Fard, S, Monahan, P, Sesso, HD, Fung, C, Williams, AM, Hamilton, RJ, Vaughn, DJ, Beard, CJ, Cook, R, Zaid, MA, Lipshultz, SE, Einhorn, LH, Oeffinger, KC, Travis, LB, and Fossa, SD. "Predicting Cardiovascular Disease among Testicular Cancer Survivors after Modern Cisplatin-Based Chemotherapy: Application of the Framingham Risk Score." Clinical Genitourinary Cancer (February 2018).

Full Text

Ramalingam, S, George, DJ, and Harrison, MR. "How we treat brain metastases in metastatic renal cell carcinoma." Clinical advances in hematology & oncology : H&O 16, no. 2 (February 2018): 110-114.

PMID
29741510
Scholars@Duke

Ast, K, Kamal, AH, Lindley, LC, Matzo, M, and Rotella, JD. "Maintaining the Momentum of Measuring What Matters: Overcoming Hurdles To Develop Electronic Clinical Quality Measures." Journal of palliative medicine 21, no. 2 (February 2018): 123-124.

PMID
29064305
Full Text

Goldsby, RE, Stratton, KL, Raber, S, Ablin, A, Strong, LC, Oeffinger, K, Sklar, CA, Armstrong, GT, Robison, LL, Bhatia, S, and Leisenring, WM. "Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report." Cancer 124, no. 3 (February 2018): 617-625.

PMID
29105081
Full Text

Ghiaseddin, A, Reardon, D, Massey, W, Mannerino, A, Lipp, ES, Herndon, JE, McSherry, F, Desjardins, A, Randazzo, D, Friedman, HS, and Peters, KB. "Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma." The oncologist 23, no. 2 (February 2018): 157-e21.

PMID
29133513
Full Text

Jones, CA, and Kamal, AH. "The Palliative Care Specialists Series: Equipping the Field for Upstream Care." Journal of palliative medicine 21, no. 2 (February 2018): 249-.

PMID
29393771
Full Text

Pages